Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Mar 13:16:163-166.
doi: 10.18632/oncotarget.28700.

No disease left behind

Muzamil Arshad, Connor Lynch, Rohan R Katipally, Sean P Pitroda, Ralph R Weichselbaum
Editorial

No disease left behind

Muzamil Arshad et al. Oncotarget. .
No abstract available

Keywords: Oncology; Radiothreapy; SBRT; ablation; immunotherapy.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

Authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1. Pathological complete response rates versus time to transplant after SABR.
Each data point represents a different study. There is no association between time to transplant after SABR and pCR rate (R2 = 0.16, p = 0.18).
See this image and copyright information in PMC

References

    1. Tsang MW. J Thorac Dis. 2016; 8:S517–27. 10.21037/jtd.2016.03.14. - DOI - PMC - PubMed
    1. Siva S, et al.. Lancet Oncol. 2022; 23:1508–16. 10.1016/S1470-2045(22)00656-8. - DOI - PubMed
    1. Gerum S, et al.. J Gastrointest Oncol. 2024; 15:1880–92. 10.21037/jgo-23-771. - DOI - PMC - PubMed
    1. van As N, et al.. N Engl J Med. 2024; 391:1413–25. 10.1056/NEJMoa2403365. - DOI - PMC - PubMed
    1. Palma DA, et al.. JAMA Oncol. 2019; 5:681–88. 10.1001/jamaoncol.2018.6993. - DOI - PMC - PubMed

Publication types

LinkOut - more resources